Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Brain wave activity modulation" is not a single molecule, receptor, or canonical therapeutic target. Instead, it refers to the process or techniques used to alter the electrical oscillatory patterns in the brain—commonly known as brain waves—which are measurable by EEG and reflect underlying neural circuit dynamics. These modulations can be achieved through various means including pharmacological agents (such as ketamine acting on NMDA receptors), noninvasive neuromodulation technologies (like focused ultrasound targeting deep brain structures such as the amygdala), and mind-body practices designed to influence stress responses and mental states. While certain drugs can induce changes in specific frequency bands of brain activity by acting on molecular targets like ion channels or neurotransmitter receptors—for example, ketamine's antagonism at NMDA receptors leading to altered gamma and delta oscillations—"brain wave activity modulation" itself is not a discrete molecular entity but rather an outcome or therapeutic goal that may involve multiple biological pathways and targets depending on context. Some non-pharmacological approaches include techniques like the "Brain Wave Modulation Technique" (BWM-T), which leverages mind-body processes for stress reduction without directly targeting a specific molecule or receptor. Similarly, new technologies such as low-intensity focused ultrasound can modulate deep-brain regions implicated in mood disorders without surgery or drugs by altering local neuronal firing patterns. Because "brain wave activity modulation" does not refer to a unique protein, gene product, receptor family member, enzyme class etc., it cannot be classified with standard molecular target conventions. It is best described as an umbrella term for diverse interventions aimed at changing neural oscillatory dynamics for therapeutic benefit. Note: If you are seeking information about specific molecules involved in modulating brain waves—such as NMDA receptors for ketamine-induced changes—you should specify those individual targets instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain wave activity modulation.